AS Geneeskunde: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AS Geneeskunde
Largest movements
- Current investments +€120,000
new in 2025: €120,000
- Cash -€16,269
down €16,269 (-11.4%), from €142,459 to €126,190
mainly Current investments (-€120,000) and Receivables after one year (-€10,000)
- Receivables after one year +€10,000
up €10,000 (+33.3%), from €30,000 to €40,000
- Reserves +€86,408
up €86,408 (+67.1%), from €128,847 to €215,254
- Tax, wage and social debts +€22,593
up €22,593 (+60.3%), from €37,496 to €60,088
- Other debts +€4,573
up €4,573 (+145%), from €3,156 to €7,729
- Gross operating margin -€57,563
down €57,563 (-34.6%), from €166,431 to €108,867
- Taxes -€14,868
down €14,868 (-39.7%), from €37,496 to €22,628
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €174,565 | €288,522 | +€113,957 | +65.3% |
| Current assets | 29/58 | €174,565 | €288,522 | +€113,957 | +65.3% |
| Amounts receivable after more than one year | 29 | €30,000 | €40,000 | +€10,000 | +33.3% |
| Other amounts receivable | 291 | €30,000 | €40,000 | +€10,000 | +33.3% |
| Amounts receivable within one year | 40/41 | €2,106 | €2,332 | +€226 | +10.7% |
| Trade receivables | 40 | €2,106 | €2,332 | +€226 | +10.7% |
| Current investments | 50/53 | - | €120,000 | +€120,000 | |
| Cash at bank and in hand | 54/58 | €142,459 | €126,190 | -€16,269 | -11.4% |
| Total equity and liabilities | 10/49 | €174,565 | €288,522 | +€113,957 | +65.3% |
| Equity | 10/15 | €133,847 | €220,254 | +€86,408 | +64.6% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €128,847 | €215,254 | +€86,408 | +67.1% |
| Distributable reserves | 133 | €128,847 | €215,254 | +€86,408 | +67.1% |
| Amounts payable | 17/49 | €40,719 | €68,268 | +€27,549 | +67.7% |
| Amounts payable within one year | 42/48 | €40,652 | €68,268 | +€27,616 | +67.9% |
| Trade debts | 44 | - | €450 | +€450 | |
| Suppliers | 440/4 | - | €450 | +€450 | |
| Taxes, remuneration and social security | 45 | €37,496 | €60,088 | +€22,593 | +60.3% |
| Taxes | 450/3 | €37,496 | €60,088 | +€22,593 | +60.3% |
| Other amounts payable | 47/48 | €3,156 | €7,729 | +€4,573 | +145% |
| Accrued charges and deferred income | 492/3 | €67 | - | -€67 | |
| Other operating charges | 640/8 | €675 | €658 | -€17 | -2.5% |
| Gross operating margin | 9900 | €166,431 | €108,867 | -€57,563 | -34.6% |
| Operating profit (loss) | 9901 | €165,756 | €108,210 | -€57,546 | -34.7% |
| Financial income | 75/76B | €750 | €875 | +€125 | +16.7% |
| Recurring financial income | 75 | €750 | €875 | +€125 | +16.7% |
| Financial charges | 65/66B | €164 | €50 | -€114 | -69.7% |
| Recurring financial charges | 65 | €164 | €50 | -€114 | -69.7% |
| Profit (loss) for the period before taxes | 9903 | €166,342 | €109,035 | -€57,307 | -34.5% |
| Income taxes | 67/77 | €37,496 | €22,628 | -€14,868 | -39.7% |
| Profit (loss) for the period | 9904 | €128,847 | €86,408 | -€42,439 | -32.9% |
| Profit (loss) for the period to be appropriated | 9905 | €128,847 | €86,408 | -€42,439 | -32.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.